Text Size
Home > Professional Resources > Publications > Trial > May 2012 > Update - May 2012
AAJ Specialty Law Reporters
Advertise with Trial
Stand out from the crowd! Advertise in Trial to reach a national audience of major decision-makers who are looking for products and services to improve their legal practices.
Online Updates
Top Story
Design defect claim against generic drugmaker is not preempted, First Circuit holds
Matthew Malamud
The Supreme Court’s holding in Mensing does not extend to state law design defect claims against generic drugmakers, a three-judge panel of the First Circuit has held, affirming a $21 million jury award to a plaintiff who was injured by the generic anti-inflammatory drug sulindac. Louis Bograd, senior litigation counsel with the Center for Constitutional Litigation in Washington, D.C., said that while the decision is important, it is a limited exception to Mensing.
Other News
- Broad Massachusetts 'disclosure and apology' program to debut
Steven M. Sellers - Debt collection firm pressured ER patients, accessed medical data
Steven M. Sellers - Suits filed against da Vinci surgical robot maker
Matthew Malamud - UPDATE: Lawsuits allege pharma coupons are illegal kickbacks
Steven M. Sellers
Verdicts & Settlements
Civil Rights
Employment Law
Negligence
Workplace Safety
Most Popular Stories
- Supreme Court expands Section 1983 qualified immunity
- Supreme Court rules 'actual damages' are just pecuniary losses under Privacy Act
- Ninth Circuit limits scope of computer fraud law
- Rethink cross-exams in traumatic brain injury cases
